L’anticorps anti-RIPK2 Polyclonal Lapin est utilisé pour la détection de RIPK2 dans des échantillons de Humain. Il a été validé pour WB, IF et IHC (p).
KO Validated
RIPK2
Reactivité: Humain
WB, ICC, IF, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Immunocytochemistry. Immunohistochemistry on paraffin sections: 5 μg/mL. Western Blot: 1: 500 & 5 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
RIPK2 belongs to the RIP subfamily of kinases. RIPK2 has an N-terminal serine/threonine kinase catalytic domain and a C-terminal caspase activation and recruitment domain (CARD). RIPK2 interacts with CD40 or the tumor necrosis factor receptor.Synonyms: CARD-containing IL-1 beta ICE-kinase, CARDIAK, RICK, RIP-2, RIP-like-interacting CLARP kinase, RIP2, Receptor-interacting protein 2, Receptor-interacting serine/threonine-protein kinase 2